Use of positron emission tomography in anticancer drug development

被引：21

作者：

Aboagye, EO ^{[1
]}

Price, PM ^{[1
]}

机构：

[1] Hammersmith Hosp, Dept Canc Med, Fac Med, Imperial Coll Sci Technol & Med,PET Oncol Grp, London, England

来源：

INVESTIGATIONAL NEW DRUGS | 2003年 / 21卷 / 02期

关键词：

positron emission tomography; pharmacokinetics; pharmacodynamics; modeling; anticancer; drug development;

D O I：

10.1023/A:1023521412787

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography (PET) is increasingly being used in anticancer drug development. The technique is applicable to studies of drug delivery, and where specific probes are available, to provide pharmacodynamic readouts noninvasively in patients. Mathematical modeling of the imaging data enhances the quality of information that is obtained from such studies. This section provides a review of the PET methodologies that have been used for the development of new cancer therapies. Other than imaging of radiolabeled drugs, PET modeling has found extensive application in studies with 2-[C-11]thymidine, [F-18]fluorodeoxyglucose, (H2O)-O-15, (CO)-O-15, and receptor ligands.

引用

收藏

页码：169 / 181

页数：13

相关论文

共 54 条

[11] SPECTRAL-ANALYSIS OF DYNAMIC PET STUDIES [J].

CUNNINGHAM, VJ ;

JONES, T .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01) :15-23

[12] Oncogenic alterations of metabolism [J].

Dang, CV ;

Semenza, GL .

TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (02) :68-72

[13] Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy [J].

Dehdashti, F ;

Flanagan, FL ;

Mortimer, JE ;

Katzenellenbogen, JA ;

Welch, MJ ;

Siegel, BA .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (01) :51-56

[14]

Dimitrakopoulou-Strauss A, 1998, J NUCL MED, V39, P465

[15]

Eary JF, 1999, CANCER RES, V59, P615

[16] Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil [J].

Findlay, M ;

Young, H ;

Cunningham, D ;

Iveson, A ;

Cronin, B ;

Hickish, T ;

Pratt, B ;

Husband, J ;

Flower, M ;

Ott, R .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :700-708

[17] HYPOXIC REGULATION OF LACTATE-DEHYDROGENASE-A - INTERACTION BETWEEN HYPOXIA-INDUCIBLE FACTOR-1 AND CAMP RESPONSE ELEMENTS [J].

FIRTH, JD ;

EBERT, BL ;

RATCLIFFE, PJ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21021-21027

[18]

Godfrey K., 1983, Compartmental models and their application

[19]

Gunn RN, 2000, J NUCL MED, V41, P706

[20] Parametric imaging of ligand-receptor interactions using a reference tissue model and cluster analysis [J].

Gunn, RN ;

Lammertsma, AA ;

Cunningham, VJ .

QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, 1998, :401-406

← 1 2 3 4 5 6 →